Peter Thiel and Longevity

Peter Thiel has been interested in cheating death for several years. He told Business Insider back in 2012, “Death is a problem that can be solved.” He’s also investing in life extension research, funding Cynthia Kenyon, Aubrey de Grey and a number of other researchers who are focused on anti-aging. Last fall, the life extension startup Unity Biotechnology also raised an enormous round of funding from Thiel and other Silicon Valley billionaires interested in the prospect of humans living much longer lives.

Methuselah Mouse Prize foundation

The Methuselah Mouse Prize (Mprize) was created to increase scientific and public interest in longevity research by awarding two cash prizes: “one to the research team that broke the world record for the oldest-ever mouse; and one to the team that developed the most successful late-onset rejuvenation strategy.” The Mprize was announced publicly in 2003 by David Gobel and Aubrey de Grey at the American Aging Association. The prize for longevity was first won by a research team led by Andrzej Bartke of Southern Illinois University. The prize for rejuvenation first went to Stephen Spindler of the University of California, Riverside. Additionally, in 2009, the first Mprize Lifespan Achievement Award went to Z. Dave Sharp of the University of Texas Health Science Center at San Antonio for extending the lifespan of already aged mice using the pharmaceutical rapamycin.

Unity Biotechnology

Working at the frontier of biotechnology and medicine, our mission is to develop therapeutics to extend the period of one’s life unburdened by disease. Our initial focus is on delivering localized therapy in ophthalmologic diseases, including diabetic macular edema and age-related macular degeneration, and age-related neurologic conditions.

Notebook for self-learning